Bluejay Diagnostics implements 1-for-50 reverse stock split effective Nov 18, 2024

Bluejay Diagnostics, Inc.

Reduces outstanding shares from ~27.6M to ~552,854, no change to par value $0.0001.
No fractional shares; cash payment in lieu based on average closing price over ten days ending Nov 18.
Trading symbol BJDX unchanged; new CUSIP 095633509.
Proportionate adjustments to all outstanding equity awards and warrants.
Stockholders with certificates receive instructions from exchange agent Continental Stock Transfer.

item 3.03 item 5.03 item 5.07 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Bluejay Diagnostics, Inc.: Amendment to Charter to implement a 1-for-50 reverse stock split (effective 2024-11-18).

Change: charter amendment
Effective: 2024-11-18

Exact text from the filing

On November 15, 2024, the Company filed a certificate of amendment to its Charter (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, to implement a 1-for-50 reverse split of its common stock (the “Reverse Stock Split”).

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

Bluejay Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-099327

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.